Phase Transfer Catalysed Asymmetric Epoxidation of Chalcones Using Chiral Crown Ethers Derived from d-Glucose and d-Mannose

Péter Bakó; Tibor Bakó; Attila Mészáros; György Keglevich; Áron Szöllősy; Sándor Bodor; Attila Makó; László Tőke

doi:10.1055/s-2004-817751

LETTER

Phase Transfer Catalysed Asymmetric Epoxidation of Chalcones Using Chiral Crown Ethers Derived from d-Glucose and d-Mannose

Péter Bakó*^a, Tibor Bakó^a, Attila Mészáros^a, György Keglevich^a, Áron Szöllősy^b, Sándor Bodor^a, Attila Makó^a, László Tőke^c
^a Department of Organic Chemical Technology, Budapest University of Technology and Economics, 1521 Budapest, P. O. Box 91, Hungary
Fax: +36(1)4633648; e-Mail: pbako@mail.bme.hu;
^b NMR Laboratory of the Institute for General and Analytical Chemistry, Budapest University of Technology and Economics, 1521 Budapest, P. O. Box 91, Hungary
^c Organic Chemical Technology Research Group of the Hungarian Academy of Sciences at the Budapest University of Technology and Economics, 1521 Budapest, P. O. Box 91, Hungary

Abstract

All articles of this category

Abstract

New chiral monoaza-15-crown-5 lariat ethers synthesized from d-mannose and the glucose-based crown ethers of similar type generated significant asymmetric induction as phase transfer catalysts in the epoxidation of chalcones with tert-butyl-hydroperoxide (80-92% ee).

Key words

chiral crown ethers - asymmetric phase transfer catalysis - lariate ether - asymmetric epoxidation

Full Text

References

1a O’Donnell MI. In Catalytic Asymmetric Synthesis, Asymmetric Phase-Transfer Reactions 2nd ed.: Ojima I. Wiley; New York: 2000. p.727

1b Comprehensive Asymmetric Catalysis Jacobsen EN. Pfaltz A. Yamamoto H. Springer; New York: 1999. p.241

2a Stoddart JF. Top. Stereochem. 1987, 17: 207

2b Miethchen R. Fehring V. Synthesis 1998, 94 ; and references cited therein

3 Bakó P. Czinege E. Bakó T. Czugler M. Tőke L. Tetrahedron: Asymmetry 1999, 10: 4539 ; and references cited therein

4a Novák T. Tatai J. Bakó P. Czugler M. Keglevich Gy. Tőke L. Synlett 2001, 424

4b Bakó T. Bakó P. Szöllősy Á. Czugler M. Keglevich Gy. Tőke L. Tetrahedron: Asymmetry 2002, 13: 203

For recent review, see:

5a Porter MJ. Roberts SM. Skidmore J. Bioorg. Med. Chem. 1999, 7: 2145

5b Banfi S. Colonna S. Molinari H. Juliá S. Guixer J. Tetrahedron 1984, 40: 5207

5c Lygo B. Wainwright PG. Tetrahedron 1999, 55: 6289

5d Corey EJ. Zhang F.-Y. Org. Lett. 1999, 1: 1287

5e Arai S. Tsuge H. Shioiri T. Tetrahedron Lett. 1998, 39: 7563

5f Enders D. Zhu J. Raabe G. Angew. Chem., Int. Ed. Engl. 1996, 35: 1725

5g Enders D. Kramps L. Zhu J. Tetrahedron: Asymmetry 1998, 9: 3959

5h Yamada K. Arai T. Sasai H. Shibasaki M. J. Org. Chem. 1998, 63: 3666

5i Watanabe S. Arai T. Sasai H. Bougauchi M. Shibasaki M. J. Org. Chem. 1998, 63: 8090

6 Bakó P. Tőke L. J. Incl. Phenom. 1995, 23: 195

7 Di Cesare P. Gross B. Synth. Commun. 1979, 4581

8 Marsman B. Wynberg H. J. Org. Chem. 1979, 44: 2312

9 Washington I. Houk KN. Org. Lett. 2002, 4: 2661

10 Juliá S. Guixer J. Masana J. Rocas J. Colonna S. Annuziata R. J. Chem. Soc., Perkin Trans. 1 1982, 1317

11

Selected data for 5: [α]_D ²⁰ +18.0 (c = 1, CHCl₃). ¹H NMR:
δ = 7.47 (d, 2 H, ArH), 7.36 (t, 3 H, ArH), 5.59 (s, 1 H, benzylidene-CH), 4.78 (s, 1 H, anomer-H), 4.24 (q, J = 10.1 Hz, 1 H, H-6), 4.06 (t, J = 9.6 Hz, 1 H, H-6), 3.66-4.00 (m, 16 H, OCH₂, H-2, H-3, H-4, H-5), 3.38 (s, 3 H, OCH₃), 3.26 (t, 2 H, CH₂I), 3.18 (t, 2 H, CH₂I). For 2a: [α]_D ²⁰ +16.0 (c = 1, CHCl₃). ¹H NMR: δ = 7.48 (d, 2 H, ArH), 7.35 (t, 3 H, ArH), 5.30 (s, 1 H, benzylidene-CH), 4.75 (s, 1 H, anomer-H), 4.24 (q, J = 10.1 Hz, 1 H, H-6), 4.11 (t, J = 9.6 Hz, 1 H, H-6), 3.55-3.98 (m, 18 H, OCH₂, H-2, H-3, H-4, H-5), 3.37 (s, 3 H, OCH₃), 2.78 (t, 6 H, CH₂N). FAB-MS: 484 [M⁺ + H], 506 [M⁺ + Na]. For 2b: [α]_D ²⁰ +15.0 (c = 1, CHCl₃). FAB-MS: 498 [M⁺ + H], 520 [M⁺ + Na]. For 2c: [α]_D ²⁰ +19.6 (c = 1, CHCl₃). ¹H NMR: δ = 7.39 (d, 2 H, ArH), 7.27 (t, 3 H, ArH), 5.52 (s, 1 H, benzylidene-CH), 4.67 (s, 1 H, anomer-H), 4.16 (q, J = 10.1 Hz, 1 H, H-6), 4.02 (t, J = 9.6 Hz, 1 H, H-6), 3.45-3.95 (m, 18 H, OCH₂, H-2, H-3, H-4, H-5), 3.31 (s, 3 H, OCH₃), 3.24 (t, 3 H, OCH₃), 2.72 (t, 4 H, CH₂N), 2.56 (t, 2 H, CH₂N), 1.69 (m, 2 H, CH₂). FAB-MS: 512 [M⁺ + H], 534 [M⁺ + Na]. For 2d: [α]_D ²⁰ +18.8 (c = 1, CHCl₃). ¹H NMR: δ = 7.71 (d, 2 H, tosyl-ArH), 7.49 (d, 2 H, tosyl-ArH), 7.38 (d, 2 H, ArH), 7.32 (t, 3 H, ArH), 5.62 (s, 1 H, benzylidene-CH), 4.74 (s, 1 H, anomer-H), 4.26 (q, J = 10.1 Hz, 1 H, H-6), 4.12 (t, J = 9.6 Hz, 1 H, H-6), 3.51-4.00 (m, 16 H, OCH₂, H-2, H-3, H-4, H-5), 3.40 (s, 3 H, OCH₃), 3.20-3.26 (m, 4 H, CH₂N), 2.44 (s, 3 H, CH₃). FAB-MS: 594 [M⁺ + H], 616 [M⁺ + Na]. For 2e: [α]_D ²⁰ +26.3 (c = 1, CHCl₃). ¹H NMR: δ = 7.47 (d, 2 H, ArH), 7.35 (t, 3 H, ArH), 5.60 (s, 1 H, benzylidene-CH), 4.78 (s, 1 H, anomer-H), 4.25 (q, J = 10.1 Hz, 1 H, H-6), 4.14 (t, J = 9.6 Hz, 1 H, H-6), 3.55-4.08 (m, 16 H, OCH₂, H-2, H-3, H-4, H-5), 3.39 (s, 3 H, OCH₃), 2.85 (t, 2 H, CH₂N), 2.76 (t, 2 H, CH₂N), 2.55 (m, 1 H, NH). FAB-MS: 440 [M⁺ + H], 462 [M⁺ + Na].

12

General Procedure for the Epoxidation of Chalcones: Chalcone (1.44 mmol) and the crown ether (0.1 mmol) were dissolved in 3 mL of toluene and 1 mL of 20% aq NaOH was added maintaining the temperature at 5 °C with ice water. Then 0.5 mL of tert-butylhydroperoxide (5.5 M decane solution, 2.88 mmol) was added and the mixture stirred at 5 °C. After completing the reaction (1-48 h), a mixture of 7 mL of toluene and 10 mL of water was added. The organic phase was dried (Na₂SO₄) and concentrated in vacuo. The crude product was purified on silica gel by preparative TLC with hexane-EtOAc (10:1) as eluent, for 7a [α]_D = -196 (c = 1, CH₂Cl₂, 20 °C) with 92% ee (lit., [α]_D -214 for the pure enantiomer); [10] mp 64-66 °C (EtOH). ¹H NMR (CDCl₃): δ = 8.02 (d, 2 H, o-COPh-H), 7.63 (t, 1 H, p-COPh-H), 7.50 (t, 2 H, m-COPh-H), 7.38-7.44 (m, 5 H, CHPh-H), 4.30 (d, J = 1.9 Hz, 1 H, COCH), 4.09 (d, J = 1.9 Hz, 1 H, PhCH). For 7c: [α]_D = -167.9 (c = 1, CH₂Cl₂, 20 °C) with 82% ee; mp 81 °C (EtOH). ¹H NMR: δ = 8.01 (d, 2 H, o-COPh-H), 7.39 (m, 5 H, CHPh-H), 6.95 (d, 2 H, m-COPh-H), 4.25 (d, J = 1.7 Hz, 1 H, COCH), 4.07 (d, J = 1.3 Hz, 1 H, PhCH), 3.87 (s, 3 H, OCH₃). For 7d: [α]_D = -156.1 (c = 1, CH₂Cl₂, 20 °C) with 80% ee; mp 121 °C (EtOH). ¹H NMR: δ = 7.96 (d, 2 H, o-COPh-H), 7.46 (d, 2 H, m-COPh-H), 7.40 (t, 3 H, m,p-CHPh-H), 7.36 (d, 2 H, o-CHPh-H), 4.23 (d, J = 1.6 Hz, 1 H, COCH), 4.07 (d, J = 1.3 Hz, 1 H, PhCH).